Plain-English translation of NCT06931821 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer mapping method called Isochronal Late Activation Mapping (ILAM) works as well as the standard voltage-based mapping method for guiding catheter ablation — a procedure that burns small areas of heart tissue to stop dangerous irregular heartbeats. You would be randomly assigned to receive ablation guided by one of these two mapping approaches.
Current ablation procedures for recurrent dangerous heart rhythms can be lengthy and may require extensive tissue destruction. Researchers believe this newer mapping technique might pinpoint problem areas more precisely, potentially making the procedure faster and more effective.
You likely qualify if…
You likely don't qualify if…
You would undergo a catheter ablation procedure where catheters (thin tubes) are guided into your heart to map the abnormal tissue. Depending on which group you're assigned to, the mapping will use either the standard voltage method or the newer ILAM method to guide where the ablation occurs. You would then be followed for one year with regular check-ups to monitor whether the procedure successfully reduced or eliminated your abnormal heart rhythms.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
United States